Investing Profile

Alaa Halawa(1)

InvestorVC
Investing in and building transformative companies at the intersection of technology and healthcare
mubadala.comLos Altos, California

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Mubadala Investor
$10K - $5.0M
$100K
14
CompanyStageDateRound SizeTotal Raised
GC Therapeutics
Series ASep 2024$65M
$65M
Co-investors: Hiroki Takai (Global Brain)
Rejuveron Life Sciences
Series BSep 2023$75M
$75M
EpiBiologics
Series AMar 2023$73M
$96M
Co-investors: David Schenkein (GV (Google Ventures)), Alexandra Cantley (Polaris Partners), Samuel Bjork (Digitalis Ventures)
Paradigm
Series AJan 2023$200M
$240M
Co-investors: Elena Viboch (General Catalyst), Hemant Taneja (General Catalyst), Ramnik Arora (FTX Ventures), Bilal Zuberi (Lux Capital), Brett Cook (F-Prime Capital Partners), Stephen Knight (F-Prime Capital Partners), Jared Friedman (Y Combinator), Jay Markowitz (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Arash Ferdowsi, Scott Belsky, Eoghan McCabe
UpStream Care
Series BDec 2022$140M
$140M
Co-investors: Eric Jones (Dragoneer Investment Group), Lynne Chou O’Keefe (Define Ventures), Chirag Shah (Define Ventures), Ayman AlAbdallah
Neumora Therapeutics
Series BOct 2022$110M
$510M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Kristina Burow (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners)
Alloy Therapeutics
Series DOct 2022$42M
Series CApr 2021$75M
$130M
Co-investors: Peter Thiel (Founders Fund), Alex Kolicich (8VC), Fabian Hansen (Presight Capital)
Pretzel Therapeutics
Series ASep 2022$73M
$73M
Co-investors: Kristina Burow (ARCH Venture Partners), Per Samuelsson (HealthCap), Robert Tansley (Cambridge Innovation Capital), Jay Parrish (ARCH Venture Partners), Reetika Bhardwaj (ARCH Venture Partners)